Sort by
Refine Your Search
-
are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Global-Scientific-Communications-Postdoctoral-Research
-
. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Global-Scientific-Communications-Postdoctoral-Research-Fellow_R135500 Copyright 2025
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Clinical-Science-Postdoctoral-Research
-
. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Zevra-Therapeutics-Global-Medical-Affairs-Postdoctoral-Research-Fellow_R137750 Copyright 2025
-
committed to creating a diverse and inclusive work environment. We are proud to be an equal opportunity employer. The main thing is that you suit us, and we suit you! BioNTech - As unique as you Overview: As
-
. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Zevra-Therapeutics-Global-Medical-Affairs-Postdoctoral-Research-Fellow_R137750 Copyright 2025
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Apellis-Pharmaceuticals-Global-Medical-Affairs-Postdoctoral
-
technologies. Responsibilities The primary function of the fellow is to create and sustain the relevant connections with the diabetes scientific community to support FreeStyle Libre products. The fellow will
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Apellis-Pharmaceuticals-Global-Medical-Affairs-Postdoctoral
-
are reviewed regularly and are subject to change. To apply, visit https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Alnylam-Pharmaceuticals-Global-Patient-Safety-and-Risk